BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 02, 2009
 |  BioCentury  |  Strategy

Bang for the buck

Bang for the buck

For 2008, Pfizer (NYSE:PFE) and Wyeth (NYSE:WYE) had operating margins of 37% and 28%, respectively, below those of big biotechs like Amgen (NASDAQ:AMGN), Genentech (NYSE:DNA) and...

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >